88 related articles for article (PubMed ID: 6548630)
21. Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system.
Balkwill FR; Moodie EM
Cancer Res; 1984 Mar; 44(3):904-8. PubMed ID: 6692412
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.
Moschella F; Torelli GF; Valentini M; Urbani F; Buccione C; Petrucci MT; Natalino F; Belardelli F; Foà R; Proietti E
Clin Cancer Res; 2013 Aug; 19(15):4249-61. PubMed ID: 23759676
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of the effectiveness of mono- and polychemotherapy for murine lymphosarcoma, resistant to apoptosis induction].
Kaledin VI; Popova NA; Andreeva EM
Vopr Onkol; 2006; 52(1):70-3. PubMed ID: 16715708
[TBL] [Abstract][Full Text] [Related]
24. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
Hagenbeek A; Carde P; Meerwaldt JH; Somers R; Thomas J; De Bock R; Raemaekers JM; van Hoof A; De Wolf-Peeters C; van Glabbeke M
J Clin Oncol; 1998 Jan; 16(1):41-7. PubMed ID: 9440721
[TBL] [Abstract][Full Text] [Related]
25. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
[TBL] [Abstract][Full Text] [Related]
26. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
Abdyldaev RA; Kruglova GV
Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
[TBL] [Abstract][Full Text] [Related]
27. Antispermatogenic effects of cyclophosphamide in the Syrian hamster.
Singh H; Hightower L; Jackson S
J Toxicol Environ Health; 1987; 22(1):29-33. PubMed ID: 3612834
[TBL] [Abstract][Full Text] [Related]
28. Interferons in the treatment of multiple myeloma.
Cooper MR
Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
[TBL] [Abstract][Full Text] [Related]
29. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
Nanjo M; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):505-9. PubMed ID: 4004283
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
Gianni AM; Bregni M; Siena S; Orazi A; Stern AC; Gandola L; Bonadonna G
J Clin Oncol; 1990 May; 8(5):768-78. PubMed ID: 2185337
[TBL] [Abstract][Full Text] [Related]
31. Irradiation- and cyclophosphamide-induced alterations in Syrian hamster T-cell population activity.
Bagasra O; Tabor D
J Leukoc Biol; 1986 Feb; 39(2):183-92. PubMed ID: 3484509
[TBL] [Abstract][Full Text] [Related]
32. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
33. Chemo- and immunotherapy of an adenovirus-induced transplantable sarcoma in hamsters.
Todorov DK; Silyanovska KK; Maneva KM; Ilarionova MV; Gantchev GT; Getov CM
Neoplasma; 1987; 34(3):287-94. PubMed ID: 3039387
[TBL] [Abstract][Full Text] [Related]
34. Interferons in the treatment of multiple myeloma.
Cooper MR; Welander CE
Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
[TBL] [Abstract][Full Text] [Related]
35. Positive interactions between interferon and chemotherapy due to direct tumor action rather than effects on host drug-metabolizing enzymes.
Balkwill FR; Mowshowitz S; Seilman SS; Moodie EM; Griffin DB; Fantes KH; Wolf CR
Cancer Res; 1984 Nov; 44(11):5249-55. PubMed ID: 6091873
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.
Schenkein DP; Dixon P; Desforges JF; Berkman E; Erban JK; Ascensao JL; Miller KB
J Clin Oncol; 1994 Nov; 12(11):2423-31. PubMed ID: 7964959
[TBL] [Abstract][Full Text] [Related]
37. VMCP chemotherapy with or without interferon-alpha-2 in newly diagnosed patients with multiple myeloma.
Preis P; Scheithauer W; Fritz E; Zielinski C; Kuehrer I; Cortelezzi A; Polli E; Baldini L; Pirker R; Kriegisch A
Onkologie; 1989 Feb; 12(1):27-9. PubMed ID: 2654788
[TBL] [Abstract][Full Text] [Related]
38. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
Vaccher E; Spina M; di Gennaro G; Talamini R; Nasti G; Schioppa O; Vultaggio G; Tirelli U
Cancer; 2001 Jan; 91(1):155-63. PubMed ID: 11148572
[TBL] [Abstract][Full Text] [Related]
39. [Results of treatment of lymphosarcoma according to the CVP program].
Shramko AF; Kruglova GV; Poddubnaia IV
Ter Arkh; 1978; 50(7):80-4. PubMed ID: 581423
[No Abstract] [Full Text] [Related]
40. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
